These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2521650)

  • 21. Noradrenergic function and the cortisol response to dexamethasone in depression.
    Rubin AL; Price LH; Charney DS; Heninger GR
    Psychiatry Res; 1985 May; 15(1):5-15. PubMed ID: 2989963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Weekly monitoring of dexamethasone suppression response in depression: its relationship to change of body weight and psychopathology.
    Gerken A; Maier W; Holsboer F
    Psychoneuroendocrinology; 1985; 10(3):261-71. PubMed ID: 4059474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychoimmunoendocrine aspects of panic disorder.
    Brambilla F; Bellodi L; Perna G; Battaglia M; Sciuto G; Diaferia G; Petraglia F; Panerai A; Sacerdote P
    Neuropsychobiology; 1992; 26(1-2):12-22. PubMed ID: 1335559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The dexamethasone suppression test in agoraphobia.
    Peterson GA; Ballenger JC; Cox DP; Hucek A; Lydiard RB; Laraia MT; Trockman C
    J Clin Psychopharmacol; 1985 Apr; 5(2):100-2. PubMed ID: 3988966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cortisol levels in plasma after dexamethasone administration and the nosology of depression.
    Sanchez Blanque A; Fernandez Canti G; Gimenez Morales JC; Juste Rullo G
    Acta Psychiatr Belg; 1985; 85(3):406-15. PubMed ID: 4050499
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What does the dexamethasone suppression test identify?
    Krishnan KR; France RD; Pelton S; McCann UD; Manepalli AN; Davidson JR
    Biol Psychiatry; 1985 Sep; 20(9):957-64. PubMed ID: 4027315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Influence of depressive history on biological parameters in major depression].
    Van Wijnendaele R; Hubain P; Dramaix M; Mendlewicz J; Linkowski P
    Encephale; 2002; 28(1):51-8. PubMed ID: 11963343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple reciprocal relationships between in vivo cellular immunity and hypothalamic-pituitary-adrenal axis in depression.
    Maes M; Meltzer HY; Stevens W; Cosyns P; Blockx P
    Psychol Med; 1994 Feb; 24(1):167-77. PubMed ID: 8208882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hypothalamic-pituitary-adrenal and hypothalamic-pituitary-thyroid axis findings in depressive disorder].
    Sarandöl A; Taneli B; Sivrioğlu Y
    Turk Psikiyatri Derg; 2003; 14(2):116-24. PubMed ID: 12844278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroendocrine interrelationships in major depressive disorder.
    Targum SD; Sullivan AC; Byrnes SM
    Am J Psychiatry; 1982 Mar; 139(3):282-6. PubMed ID: 6800269
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A multivariate study of simultaneous escape from suppression by dexamethasone of urinary free cortisol, plasma cortisol, adrenocorticotropic hormone and beta-endorphin in melancholic patients.
    Maes M; Vandervorst C; Suy E; Minner B; Raus J
    Acta Psychiatr Scand; 1991 Jun; 83(6):480-91. PubMed ID: 1652880
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression.
    Wichniak A; Brunner H; Ising M; Pedrosa Gil F; Holsboer F; Friess E
    Psychoneuroendocrinology; 2004 Oct; 29(9):1101-8. PubMed ID: 15219633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: results from a large cohort study.
    Vreeburg SA; Hoogendijk WJ; van Pelt J; Derijk RH; Verhagen JC; van Dyck R; Smit JH; Zitman FG; Penninx BW
    Arch Gen Psychiatry; 2009 Jun; 66(6):617-26. PubMed ID: 19487626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypothalamic-pituitary-adrenal axis activity and age in major depression.
    Nelson WH; Orr WW; Shane SR; Stevenson JM
    J Clin Psychiatry; 1984 Mar; 45(3):120-1. PubMed ID: 6698943
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The dexamethasone suppression test in depressed retarded adults: preliminary findings.
    Beckwith BE; Parker L; Pawlarczyk D; Couk DI; Schumacher KS; Yearwood K
    Biol Psychiatry; 1985 Aug; 20(8):825-31. PubMed ID: 4027299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypothalamic-pituitary-adrenal axis activity and tricyclic response in major depression.
    Nelson WH; Orr WW; Stevenson JM; Shane SR
    Arch Gen Psychiatry; 1982 Sep; 39(9):1033-6. PubMed ID: 7115012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lithium augmentation increases post-dexamethasone cortisol in the dexamethasone suppression test in unipolar major depression.
    Bschor T; Baethge C; Adli M; Eichmann U; Ising M; Uhr M; Müller-Oerlinghausen B; Bauer M
    Depress Anxiety; 2003; 17(1):43-8. PubMed ID: 12577277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and magnetic resonance imaging correlates of hypothalamic-pituitary-adrenal axis function in depression and Alzheimer's disease.
    O'Brien JT; Ames D; Schweitzer I; Colman P; Desmond P; Tress B
    Br J Psychiatry; 1996 Jun; 168(6):679-87. PubMed ID: 8773809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative dexamethasone suppression test measurements in bulimia, depression and normal controls.
    Musisi S; Garfinkel P
    Can J Psychiatry; 1985 Apr; 30(3):190-4. PubMed ID: 3857956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dexamethasone suppression test and sleep deprivation in endogenous depression.
    Kuhs H
    J Affect Disord; 1985 Sep; 9(2):121-6. PubMed ID: 2932484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.